R. Jackson Forcier
- Oncology top 10%
- Molecular Biology
- Epidemiology
- Pulmonary and Respiratory Medicine
- Hematology top 10%
- Co-authors
- L. Herbert MaurerRobert T. EaganSalvatore A. Del PreteWalter B. FormanLeo R. ZacharskiWilliam G. HendersonFrederick R. RicklesC.J. Cornell
- Topics
- Neuroendocrine Tumor Research Advances (4 papers)Lung Cancer Research Studies (4 papers)Venous Thromboembolism Diagnosis and Management (3 papers)
- Cited by
- Internal MedicineOncologyHematology
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
R. Jackson Forcier
18 papers receiving 704 citations
Peers
Comparison fields: 5 of 71
- Oncology 427
- Molecular Biology 207
- Epidemiology 149
- Pulmonary and Respiratory Medicine 133
- Hematology 112
Countries citing papers authored by R. Jackson Forcier
This map shows the geographic impact of R. Jackson Forcier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Jackson Forcier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Jackson Forcier more than expected).
Fields of papers citing papers by R. Jackson Forcier
This network shows the impact of papers produced by R. Jackson Forcier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Jackson Forcier. The network helps show where R. Jackson Forcier may publish in the future.
Co-authorship network of co-authors of R. Jackson Forcier
This figure shows the co-authorship network connecting the top 25 collaborators of R. Jackson Forcier. A scholar is included among the top collaborators of R. Jackson Forcier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Jackson Forcier. R. Jackson Forcier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 46 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 128 | |
| 5 | Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma. | 187 |
| 6 | 46 | |
| 7 | 2 | |
| 8 | 3 | |
| 9 | 21 | |
| 10 | 33 | |
| 11 | 87 | |
| 12 | 9 | |
| 13 | Clinical trial of combined therapy with adriamycin and cis-dichlorodiammineplatinum(II). | 3 |
| 14 | 106 | |
| 15 | 49 | |
| 16 | Combination chemotherapy and radiation therapy for small cell carcinoma of the lung. | 5 |
| 17 | 28 | |
| 18 | Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia. | 28 |
About R. Jackson Forcier
R. Jackson Forcier is a scholar working on Internal Medicine, Oncology and Genetics, having authored 18 papers that have together received 785 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (4 papers), Lung Cancer Research Studies (4 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). The work is most often cited by research in Internal Medicine (100 citations), Oncology (427 citations) and Hematology (112 citations). R. Jackson Forcier has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include L. Herbert Maurer, Robert T. Eagan, Salvatore A. Del Prete, Walter B. Forman, Leo R. Zacharski, William G. Henderson, Frederick R. Rickles, C.J. Cornell, Elwood Headley and Hau C. Kwaan. Their work appears in journals such as Annals of Internal Medicine, Cancer and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.